Championing ‘innovative ideas and approaches’, the Orrick, Herrington & Sutcliffe LLP practice has extensive experience representing clients from across the tech, life sciences, and energy sectors, regularly handling strategic acquisitions, minority investments, and sales of equity interests. In addition to maintaining offices across the country, the team frequently leverages its firmwide international network to handle multi-jurisdictional corporate transactions. Leading from New York, David Ruff is an expert on majority investments and joint ventures, whilst the ’incredible’ David Schwartz focuses on complex de-SPAC transactions. In Silicon Valley, Mark Seneca regularly represents unicorns and venture-backed companies, and Matthew Gemello is knowledgeable on public takeovers. In Washington DC, Tony Chan is a key contact regarding corporate governance affairs, San Francisco-based Leah Recht is a key contact for divestitures, and New York’s David Gold is also highly recommended.
Legal 500 Editorial commentary
- Profile
- Social
Testimonials
Collated independently by Legal 500 research team.
‘The team at Orrick take the time to understand the nature and demands of our business. They provide considered legal advice on complex topics in a way which is actionable for our business. They challenge our thinking when appropriate and are also responsive to feedback. The present innovative ideas and approaches to complex M&A matters.’
‘David Schwartz is an incredible relationship partner. His dedication to understanding our business and our ways of working is complimented by his proactive approach to providing innovative solutions and ideas.’
‘Orrick had timely, direct, and experienced advice to offer during our M&A transaction. Their main partner, Mark Seneca, was extremely well versed and easy to work with.’
‘Mark Seneca is very hard working and available.’
‘Orrick's approach has suited our needs very well, with a very strong client/lead partner relationship, fast and accurate responses, and a good record of both responding to the client's directions and contributing additional thinking and perspective. Particularly useful, the lead partner for our engagements has a very good record of understanding quickly both the legal and business context, including why some legal risks need to be subordinate to the business gains for a particular issue.’
Key clients
- ANI Pharmaceuticals, Inc.
- Aptean, Inc.
- Bayer AG
- Casetext, Inc.
- Catalyst Biosciences
- Chainalysis, Inc.
- Chevron New Energies
- Eversight, Inc.
- Fuwei Films (Holdings) Co., Ltd.
- Green Street Power Partners
Work highlights
- Advised MosaicML on its estimated $1.3bn acquisition by Databricks.
- Advised Ipsen SA on its tender offer and $952m acquisition of Albireo Pharma Inc.
- Advised Superior Plus on its acquisition of Certarus in a deal valued at CA$1.05bn.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Mark Seneca
Practice head
David Ruff
Other key lawyers
David Schwartz; Mark Seneca; Tony Chan; Matthew Gemello; David Gold; Leah Recht